BDBM27955 (-)-Zilpaterol::(9R,10R)-9-hydroxy-10-(propan-2-ylamino)-1,3-diazatricyclo[6.4.1.0^{4,13}]trideca-4(13),5,7-trien-2-one

SMILES CC(C)N[C@@H]1CCn2c3c(cccc3[nH]c2=O)[C@H]1O

InChI Key InChIKey=ZSTCZWJCLIRCOJ-DGCLKSJQSA-N

Data  2 KI  2 IC50  2 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 27955   

TargetBeta-2 adrenergic receptor(Homo sapiens (Human))
Intervet Innovation

LigandPNGBDBM27955((-)-Zilpaterol | (9R,10R)-9-hydroxy-10-(propan-2-y...)
Affinity DataKi:  320nM ΔG°:  -8.77kcal/mole IC50:  620nM EC50:  8.70nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Intervet Innovation

LigandPNGBDBM27955((-)-Zilpaterol | (9R,10R)-9-hydroxy-10-(propan-2-y...)
Affinity DataKi:  1.30E+5nM ΔG°:  -5.24kcal/mole IC50:  3.20E+5nM EC50: >1.00E+6nMpH: 7.4 T: 2°CAssay Description:In the binding assays, the results were expressed as percent inhibition of the control radioligand specific binding. The IC50 values (concentration c...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed